A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.

@article{Zahoor2015APA,
  title={A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.},
  author={Haris Zahoor and James D. Luketich and Ryan Levy and Omar Awais and Daniel G. Winger and Michael K Gibson and Katie Sue Nason},
  journal={The Journal of thoracic and cardiovascular surgery},
  year={2015},
  volume={149 2},
  pages={538-47}
}
OBJECTIVES Prognosis for patients with locally advanced esophagogastric adenocarcinoma (EAC) is poor with surgery alone, and adjuvant therapy after open esophagectomy is frequently not tolerated. After minimally invasive esophagectomy (MIE); however, earlier return to normal function may render patients better able to receive adjuvant therapy. We examined whether primary MIE followed by adjuvant chemotherapy influenced survival compared with propensity-matched patients treated with neoadjuvant… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2003
View 4 Excerpts
Highly Influenced

Statistical Software: Release 13

StataCorp. Stata
College Station, TX: StataCorp LP; • 2013
View 2 Excerpts

Similar Papers

Loading similar papers…